Organon & Co (OGN)
14.26
+0.13
(+0.92%)
USD |
NYSE |
Apr 02, 12:25
Organon Max Drawdown (5Y)
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Alnylam Pharmaceuticals Inc | 42.46% |
| Palatin Technologies Inc | 98.13% |
| Vertex Pharmaceuticals Inc | 41.60% |
| Agios Pharmaceuticals Inc | 82.86% |
| Blueprint Medicines Corp | 69.50% |